Establishment and Evaluation of Prognostic Prediction Model for Diffuse Large B-Cell Lymphoma Patients Based on International Prognostic Index and FAT4, TP53 Mutation
This study demonstrates that integrating genetic mutation status enhances the prognostic value of the IPI scoring system. Our model may serve as a valuable tool for predicting the prognosis of DLBCL patients receiving rituximab-based immunotherapy.
Authors
- Guzailinuer Wufuer
- Xiaolong Qi (ORCID: https://orcid.org/0000-0002-3559-5855)
- Qiping Shi (ORCID: https://orcid.org/0000-0002-2866-3266)
- Qin Huang (ORCID: https://orcid.org/0000-0003-2452-9884)
- An Li (ORCID: https://orcid.org/0000-0001-5750-526X)
- Zhen Kou (ORCID: https://orcid.org/0000-0002-7689-5969)
- Li Shao (ORCID: https://orcid.org/0000-0002-3172-9879)
- Zengsheng Wang
- Abulaiti Renaguli
- Yan Li (ORCID: https://orcid.org/0000-0002-2867-933X)
- Shunsheng Zhai
Institutions
- Genesee Community College (US)
Publication Details
- Journal
- Acta Haematologica
- Published
- 2025-10-02
- DOI
- https://doi.org/10.1159/000548543
- Citations
- 1
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.47